URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Karl Kieburtz

Concepts (462)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Parkinson Disease
50
1991
394
9.210
Why?
Huntington Disease
22
1994
121
5.340
Why?
Neuroprotective Agents
15
1996
113
3.570
Why?
Clinical Trials as Topic
21
1996
664
3.530
Why?
Antiparkinson Agents
16
1998
110
2.590
Why?
Levodopa
16
1991
112
2.270
Why?
Humans
127
1986
35000
1.710
Why?
Hot Flashes
3
2003
28
1.690
Why?
Movement Disorders
5
2002
50
1.650
Why?
Research Design
12
1996
326
1.610
Why?
Middle Aged
67
1990
9461
1.540
Why?
AIDS Dementia Complex
12
1991
143
1.520
Why?
Ubiquinone
8
1996
24
1.410
Why?
Female
80
1990
19061
1.350
Why?
Monoamine Oxidase Inhibitors
5
2000
39
1.340
Why?
HIV Infections
12
1990
600
1.300
Why?
Research Subjects
4
2008
16
1.280
Why?
Male
78
1990
18870
1.260
Why?
Disease Progression
22
1994
496
1.240
Why?
Severity of Illness Index
13
2000
878
1.220
Why?
Dementia
4
1990
91
1.190
Why?
Double-Blind Method
26
1996
985
1.180
Why?
Biomedical Research
2
2007
132
1.070
Why?
Cognition Disorders
9
1991
262
1.040
Why?
Neurology
3
1996
82
0.950
Why?
Neuropsychological Tests
22
1993
355
0.940
Why?
Treatment Outcome
27
1993
2487
0.920
Why?
Postmenopause
3
2003
42
0.920
Why?
Acquired Immunodeficiency Syndrome
6
1989
207
0.890
Why?
Benzothiazoles
3
2004
54
0.890
Why?
Aged
37
1990
6986
0.880
Why?
Outcome Assessment (Health Care)
5
2005
275
0.880
Why?
Brain
7
1990
1161
0.870
Why?
Adult
47
1990
10906
0.850
Why?
Parkinsonian Disorders
2
2000
26
0.840
Why?
Cognition
8
1990
216
0.810
Why?
Neurosurgery
1
2012
6
0.800
Why?
Antipsychotic Agents
2
2010
96
0.800
Why?
Homocysteine
2
2008
25
0.790
Why?
Attitude to Health
2
2006
198
0.790
Why?
Neurosurgical Procedures
5
2005
29
0.780
Why?
Evidence-Based Medicine
4
2002
197
0.780
Why?
Gene Transfer Techniques
3
2006
145
0.770
Why?
Drug Therapy
1
2011
45
0.760
Why?
Excitatory Amino Acid Antagonists
2
1999
36
0.740
Why?
Cyclohexanecarboxylic Acids
3
2003
47
0.730
Why?
Dietary Supplements
2
2005
43
0.720
Why?
Amines
3
2003
64
0.720
Why?
gamma-Aminobutyric Acid
3
2003
90
0.710
Why?
Selegiline
4
1994
69
0.700
Why?
tau Proteins
1
2011
94
0.680
Why?
Clinical Trials, Phase I as Topic
2
1991
11
0.680
Why?
Ophthalmology
1
2009
17
0.680
Why?
Dyskinesia, Drug-Induced
2
2008
13
0.680
Why?
Methionine
1
2009
52
0.670
Why?
Decision Making
3
2006
220
0.670
Why?
Memory Disorders
2
2006
42
0.670
Why?
Indoles
1
2010
93
0.660
Why?
Thiazolidinediones
1
2009
62
0.650
Why?
Catechols
3
2000
11
0.650
Why?
Dopamine Agonists
2
2006
29
0.650
Why?
Neurofilament Proteins
1
2008
21
0.640
Why?
Neurologic Examination
14
1991
143
0.630
Why?
Consent Forms
1
2008
4
0.630
Why?
Isoleucine
1
2008
11
0.630
Why?
Ethics Committees, Research
1
2008
17
0.620
Why?
Trust
1
2008
28
0.620
Why?
Valine
1
2008
32
0.620
Why?
Perception
1
2008
60
0.610
Why?
Calcium Channel Blockers
1
2008
66
0.600
Why?
Therapeutics
1
2007
6
0.580
Why?
Magnetic Resonance Imaging
8
1990
928
0.570
Why?
Zidovudine
4
1991
69
0.550
Why?
Ethics, Research
2
2005
16
0.550
Why?
Third-Party Consent
1
2006
5
0.540
Why?
Drug Therapy, Combination
8
1992
375
0.540
Why?
Proxy
1
2006
14
0.540
Why?
Human Experimentation
1
2006
14
0.530
Why?
Advance Directives
1
2006
20
0.530
Why?
Mental Competency
1
2006
24
0.530
Why?
Drug Administration Schedule
5
1996
362
0.520
Why?
Rural Population
1
2006
70
0.520
Why?
Follow-Up Studies
18
1992
1757
0.520
Why?
Therapeutic Human Experimentation
1
2005
4
0.520
Why?
Catechol O-Methyltransferase
3
2000
5
0.520
Why?
Welding
1
2005
5
0.510
Why?
Randomized Controlled Trials as Topic
8
2002
400
0.510
Why?
Manganese Poisoning
1
2005
11
0.500
Why?
Cohort Studies
14
1996
912
0.490
Why?
Informed Consent
4
2006
77
0.480
Why?
Uric Acid
3
2008
49
0.480
Why?
Quality of Life
6
2003
486
0.470
Why?
Time Factors
9
1993
3047
0.470
Why?
Data Collection
1
2005
201
0.470
Why?
Dose-Response Relationship, Drug
9
1992
1085
0.460
Why?
Occupational Exposure
1
2005
110
0.450
Why?
Biological Markers
11
1994
532
0.440
Why?
Practice Guidelines as Topic
1
2006
288
0.440
Why?
Physician's Practice Patterns
1
2006
223
0.440
Why?
Placebos
4
2000
177
0.440
Why?
Indans
4
2002
19
0.430
Why?
Alzheimer Disease
1
2006
252
0.430
Why?
Retrospective Studies
7
1991
2167
0.420
Why?
HIV-1
3
1995
544
0.420
Why?
Acetates
1
2003
64
0.420
Why?
Interferon-beta
1
2002
60
0.400
Why?
Cerebrovascular Disorders
2
1992
111
0.400
Why?
Headache
2
1995
46
0.390
Why?
Antioxidants
5
2002
200
0.390
Why?
Pain
2
1998
363
0.380
Why?
Epilepsy, Temporal Lobe
2
2010
33
0.380
Why?
Multiple Sclerosis
1
2002
125
0.380
Why?
Risk Assessment
4
2005
808
0.370
Why?
Acetamides
3
1996
30
0.370
Why?
Disease Models, Animal
3
2000
908
0.360
Why?
Dehydroepiandrosterone Sulfate
1
2000
7
0.360
Why?
Translational Medical Research
2
2010
36
0.360
Why?
Benzophenones
1
2000
1
0.350
Why?
Autonomic Nervous System
1
2000
69
0.350
Why?
Vitamin E
2
1994
87
0.350
Why?
Administration, Oral
5
2002
302
0.340
Why?
HIV Seropositivity
1
2000
32
0.340
Why?
Peripheral Nervous System Diseases
3
1991
99
0.340
Why?
Mice, SCID
1
2000
170
0.330
Why?
Behavioral Symptoms
2
2006
12
0.330
Why?
Amitriptyline
1
1998
8
0.320
Why?
Mexiletine
1
1998
12
0.320
Why?
Adrenergic Uptake Inhibitors
1
1998
21
0.320
Why?
Viral Load
3
2000
138
0.320
Why?
Peer Review, Research
1
1998
24
0.320
Why?
Nervous System Diseases
2
1991
141
0.320
Why?
RNA, Viral
3
2004
274
0.320
Why?
Conflict of Interest
1
1998
35
0.310
Why?
Anti-Arrhythmia Agents
1
1998
80
0.300
Why?
Carbidopa
2
2004
18
0.300
Why?
Analysis of Variance
7
1998
705
0.300
Why?
Motor Activity
4
2000
179
0.300
Why?
Mental Status Schedule
3
1997
26
0.300
Why?
Nitriles
3
2000
39
0.290
Why?
China
3
2005
89
0.290
Why?
Periodicals as Topic
1
1998
77
0.280
Why?
Placebo Effect
4
1999
36
0.280
Why?
Cross-Sectional Studies
4
2005
627
0.280
Why?
Publishing
1
1997
45
0.270
Why?
Didanosine
2
1992
21
0.270
Why?
Health Maintenance Organizations
2
1986
26
0.260
Why?
Drug Utilization
2
1986
44
0.260
Why?
Proportional Hazards Models
6
2001
398
0.260
Why?
Sex Distribution
2
2005
142
0.250
Why?
Receptors, N-Methyl-D-Aspartate
2
1991
81
0.250
Why?
Prevalence
3
2005
530
0.250
Why?
Longitudinal Studies
8
1998
372
0.250
Why?
Age Distribution
2
2005
201
0.250
Why?
Coenzymes
5
1996
23
0.250
Why?
Antiretroviral Therapy, Highly Active
3
2002
67
0.240
Why?
Case-Control Studies
5
1996
587
0.240
Why?
Repetitive Sequences, Nucleic Acid
1
1994
81
0.230
Why?
United States
4
1986
2511
0.230
Why?
Corpus Striatum
4
1996
151
0.230
Why?
Data Interpretation, Statistical
3
2005
154
0.230
Why?
Aged, 80 and over
5
2005
2423
0.230
Why?
CD4 Lymphocyte Count
6
1997
147
0.220
Why?
Muscular Diseases
1
1994
67
0.220
Why?
Activities of Daily Living
5
1996
250
0.220
Why?
Anticonvulsants
2
2010
96
0.210
Why?
Multicenter Studies as Topic
3
1996
126
0.210
Why?
Clinical Trials, Phase II as Topic
2
2006
13
0.210
Why?
Trinucleotide Repeats
2
1999
41
0.210
Why?
United States Food and Drug Administration
2
2009
42
0.210
Why?
Seizures
2
1990
123
0.210
Why?
Nontherapeutic Human Experimentation
1
2012
4
0.210
Why?
Chickenpox
1
1992
20
0.210
Why?
Sex Factors
5
1995
561
0.210
Why?
Brain Diseases
2
1989
125
0.200
Why?
Dopamine
2
1991
192
0.200
Why?
AIDS-Related Complex
1
1992
14
0.200
Why?
Dopamine Agents
3
2005
31
0.200
Why?
Neurodegenerative Diseases
1
2012
41
0.200
Why?
Area Under Curve
2
2007
61
0.190
Why?
Movement
2
2009
162
0.190
Why?
Dopamine Antagonists
1
2011
22
0.190
Why?
Psychomotor Disorders
2
1997
18
0.190
Why?
Fatty Acids, Omega-3
1
2011
21
0.190
Why?
Heart Rate
2
2000
449
0.190
Why?
Vitamin B 12
1
1991
23
0.190
Why?
Vitamins
2
2007
31
0.190
Why?
Bipolar Disorder
1
1991
44
0.190
Why?
History, 21st Century
1
2011
47
0.190
Why?
Aneurysm, Dissecting
1
1991
19
0.190
Why?
Capacity Building
1
2010
4
0.190
Why?
Neurturin
1
2010
1
0.190
Why?
Polyneuropathies
2
2000
41
0.180
Why?
Academies and Institutes
1
2010
11
0.180
Why?
Incidence
7
2001
644
0.180
Why?
Animals
7
1996
15647
0.180
Why?
Comorbidity
3
2005
365
0.180
Why?
Temporal Lobe
1
2012
110
0.180
Why?
Caudate Nucleus
2
1996
22
0.180
Why?
Carotid Artery Diseases
1
1991
53
0.180
Why?
Carbazoles
1
2010
27
0.180
Why?
Drug Design
1
2010
45
0.180
Why?
Riluzole
1
2010
2
0.180
Why?
Endarterectomy
1
1990
9
0.180
Why?
Dependovirus
1
2010
56
0.180
Why?
Statistics, Nonparametric
2
1998
251
0.180
Why?
Amyotrophic Lateral Sclerosis
1
2010
40
0.180
Why?
History, 20th Century
1
2011
232
0.170
Why?
Research
2
1996
169
0.170
Why?
Therapeutic Misconception
1
2009
3
0.170
Why?
Orphan Drug Production
1
2009
6
0.170
Why?
Academic Medical Centers
1
2010
93
0.170
Why?
Intestinal Absorption
1
2009
63
0.170
Why?
Opportunistic Infections
1
1989
19
0.170
Why?
Drug Approval
1
2009
19
0.170
Why?
Eye Diseases
1
2009
45
0.170
Why?
Risk
2
2006
343
0.160
Why?
Neuromuscular Diseases
1
1989
50
0.160
Why?
Probability
3
2003
289
0.160
Why?
Carotid Arteries
1
1990
96
0.160
Why?
Comprehension
1
2009
26
0.160
Why?
Oxycodone
1
2009
10
0.160
Why?
Medical Records
1
2009
122
0.160
Why?
Psychomotor Performance
3
1998
157
0.160
Why?
Delayed-Action Preparations
1
2009
41
0.160
Why?
Cross-Over Studies
2
1996
117
0.160
Why?
Observer Variation
3
2002
137
0.160
Why?
Forecasting
2
2005
172
0.160
Why?
Patient Participation
1
2009
71
0.160
Why?
Dystonia
1
2008
20
0.160
Why?
Motor Skills Disorders
2
2004
7
0.160
Why?
Societies, Medical
1
2009
132
0.150
Why?
Causality
2
1996
43
0.150
Why?
Age of Onset
3
1994
120
0.150
Why?
Diagnosis, Differential
2
1995
855
0.150
Why?
Herpes Zoster
1
2009
60
0.150
Why?
Ethics, Clinical
1
2008
11
0.150
Why?
Capsules
1
2007
5
0.150
Why?
Gelatin
1
2007
14
0.150
Why?
Trinucleotide Repeat Expansion
1
2008
50
0.150
Why?
Back Pain
1
2007
18
0.150
Why?
Biological Availability
1
2007
39
0.150
Why?
Adolescent
4
1994
4513
0.150
Why?
Prospective Studies
6
1994
1606
0.150
Why?
Educational Status
2
2000
172
0.150
Why?
Sinusitis
1
2007
23
0.150
Why?
Tumor Necrosis Factor-alpha
4
2002
627
0.150
Why?
Pruritus
1
2007
19
0.150
Why?
Akathisia, Drug-Induced
1
2007
7
0.150
Why?
Recognition (Psychology)
1
2007
12
0.150
Why?
Safe Sex
1
2007
5
0.140
Why?
Sample Size
2
2000
32
0.140
Why?
Enzyme-Linked Immunosorbent Assay
1
2008
459
0.140
Why?
Oxepins
1
2006
1
0.140
Why?
Population Growth
1
2006
6
0.140
Why?
Food-Drug Interactions
1
2006
1
0.140
Why?
Tyramine
1
2006
3
0.140
Why?
Pilot Projects
3
2000
426
0.140
Why?
Drug Evaluation, Preclinical
1
2007
72
0.140
Why?
Internationality
1
2006
22
0.140
Why?
Population Density
1
2006
14
0.140
Why?
Emotions
1
2007
87
0.140
Why?
Models, Animal
1
2007
131
0.130
Why?
Drug Information Services
1
1986
5
0.130
Why?
Diagnostic Imaging
1
2007
81
0.130
Why?
Rural Health
1
2006
24
0.130
Why?
Reference Values
2
2003
427
0.130
Why?
Neurons
3
1991
1053
0.130
Why?
Personal Autonomy
1
2006
48
0.130
Why?
Malnutrition
1
2005
3
0.130
Why?
Melanoma
1
2007
133
0.130
Why?
Prognosis
4
1995
1030
0.130
Why?
Cell Survival
1
2007
537
0.120
Why?
Metals
1
2005
54
0.120
Why?
Internal Medicine
1
1986
94
0.120
Why?
Electrocardiography
1
2010
719
0.120
Why?
Radiopharmaceuticals
1
2005
48
0.120
Why?
Nonlinear Dynamics
1
2005
35
0.120
Why?
Verbal Learning
2
2000
31
0.120
Why?
Physicians, Family
1
1986
98
0.120
Why?
Anti-Retroviral Agents
1
2004
25
0.120
Why?
Diet
1
2006
196
0.120
Why?
Mortality
1
2005
87
0.120
Why?
Chi-Square Distribution
4
2002
320
0.120
Why?
Substantia Nigra
1
2005
73
0.120
Why?
Interpersonal Relations
1
2006
161
0.120
Why?
Neurons, Afferent
1
2005
94
0.120
Why?
Health Surveys
1
2005
198
0.120
Why?
Blood Pressure
1
2006
446
0.120
Why?
Predictive Value of Tests
4
2001
579
0.120
Why?
Mass Screening
1
2006
223
0.120
Why?
Young Adult
1
2008
1013
0.120
Why?
Skin Neoplasms
1
2007
225
0.120
Why?
Immune System
1
2005
72
0.120
Why?
Neoplasms
1
2010
701
0.110
Why?
Regression Analysis
2
2000
489
0.110
Why?
Thiazoles
1
2004
85
0.110
Why?
Risk Factors
6
2001
2172
0.110
Why?
Peripheral Nerves
2
1998
48
0.110
Why?
Communication
1
2006
245
0.110
Why?
Butanes
1
2002
3
0.110
Why?
Nitrogen Oxides
1
2002
14
0.110
Why?
Disabled Persons
1
2002
53
0.100
Why?
Tocopherols
1
2002
25
0.100
Why?
Patient Selection
3
2002
197
0.100
Why?
Smoking
1
2006
387
0.100
Why?
Brain Tissue Transplantation
2
1996
23
0.100
Why?
Matrix Metalloproteinase 2
3
2004
35
0.100
Why?
Apoptosis
1
2007
782
0.090
Why?
Cytokines
1
2004
555
0.090
Why?
Models, Biological
1
2006
982
0.090
Why?
Drug Resistance
2
2010
97
0.090
Why?
Patient Satisfaction
1
2003
216
0.090
Why?
beta 2-Microglobulin
1
2000
20
0.090
Why?
Aging
1
2006
692
0.090
Why?
Chemokine CCL2
3
2004
124
0.090
Why?
Anti-HIV Agents
2
1997
179
0.090
Why?
Nitrophenols
1
2000
5
0.090
Why?
Th1 Cells
1
2000
72
0.090
Why?
Administration, Cutaneous
1
2000
33
0.090
Why?
Electroencephalography
2
1990
133
0.090
Why?
Th2 Cells
1
2000
89
0.080
Why?
Respiration
1
2000
176
0.080
Why?
Interleukin-4
1
2000
160
0.080
Why?
Mental Recall
1
2000
57
0.080
Why?
Confidence Intervals
3
2002
155
0.080
Why?
Leucine
1
1999
108
0.080
Why?
Platelet Activating Factor
1
1999
39
0.080
Why?
Imidazoles
1
1999
63
0.080
Why?
Reproducibility of Results
4
1997
859
0.080
Why?
Neuritis
1
1998
16
0.080
Why?
HIV
1
1999
73
0.080
Why?
Genes, Dominant
1
1999
78
0.080
Why?
Questionnaires
3
2006
942
0.080
Why?
Interferon-gamma
1
2000
340
0.080
Why?
Positron-Emission Tomography
2
2005
35
0.070
Why?
Psychiatric Status Rating Scales
3
1995
306
0.070
Why?
DNA
2
1994
831
0.070
Why?
Immunoglobulins, Intravenous
1
1997
38
0.070
Why?
Vasculitis
1
1997
28
0.070
Why?
Drug Evaluation
2
1992
98
0.070
Why?
Fetal Tissue Transplantation
1
1996
23
0.070
Why?
Atrophy
1
1996
61
0.070
Why?
Reaction Time
2
2006
200
0.060
Why?
Macrophage Colony-Stimulating Factor
2
2004
22
0.060
Why?
Drug Interactions
1
1995
176
0.060
Why?
Hippocampus
1
1996
186
0.060
Why?
Tomography, Emission-Computed, Single-Photon
2
2004
65
0.060
Why?
Psychometrics
3
1997
212
0.060
Why?
Basal Ganglia Diseases
2
2003
16
0.060
Why?
Creatine Kinase
1
1994
51
0.060
Why?
Electromyography
1
1994
170
0.050
Why?
Pentetic Acid
1
1993
36
0.050
Why?
Angiography, Digital Subtraction
1
1992
23
0.050
Why?
Organometallic Compounds
1
1993
71
0.050
Why?
Toxicity Tests, Chronic
1
2012
1
0.050
Why?
Toxicity Tests, Acute
1
2012
3
0.050
Why?
Treatment Failure
1
2012
125
0.050
Why?
Gadolinium
1
1991
18
0.050
Why?
Social Behavior
1
2012
70
0.050
Why?
Leukocyte Count
1
1992
152
0.050
Why?
Meninges
1
1991
18
0.050
Why?
Dogs
1
2012
465
0.050
Why?
Psychological Tests
1
1991
76
0.050
Why?
Parenteral Nutrition
1
1991
23
0.050
Why?
Spinal Cord Diseases
1
1991
12
0.050
Why?
Carotid Artery, Internal
1
1991
28
0.050
Why?
Putamen
1
2010
14
0.050
Why?
Amobarbital
1
2010
6
0.050
Why?
Drug Toxicity
1
2010
14
0.050
Why?
Algorithms
2
2003
518
0.050
Why?
Dominance, Cerebral
1
2010
43
0.050
Why?
Phenytoin
1
1990
17
0.040
Why?
Lorazepam
1
1990
15
0.040
Why?
Base Sequence
1
1994
1681
0.040
Why?
Spinal Cord
1
1991
153
0.040
Why?
Image Enhancement
1
1991
139
0.040
Why?
Molecular Sequence Data
1
1994
1993
0.040
Why?
Medication Adherence
1
2009
18
0.040
Why?
Texas
1
2009
32
0.040
Why?
Feasibility Studies
1
2009
189
0.040
Why?
Syndrome
1
1989
203
0.040
Why?
CD4-Positive T-Lymphocytes
1
1992
299
0.040
Why?
Virus Diseases
1
1989
82
0.040
Why?
Mice
1
2000
5900
0.040
Why?
Enzyme Inhibitors
1
2010
396
0.040
Why?
Motivation
1
2009
148
0.040
Why?
Analgesics, Opioid
1
2009
96
0.040
Why?
Demography
1
2008
95
0.040
Why?
Single-Blind Method
1
2008
114
0.040
Why?
Anger
1
2007
15
0.040
Why?
Facial Expression
1
2007
14
0.040
Why?
Social Perception
1
2007
28
0.040
Why?
Fear
1
2007
45
0.040
Why?
Pattern Recognition, Visual
1
2007
38
0.040
Why?
Acute Disease
1
2009
570
0.040
Why?
Morbidity
1
2007
70
0.030
Why?
Pergolide
1
2006
2
0.030
Why?
Bromocriptine
1
2006
8
0.030
Why?
Health Knowledge, Attitudes, Practice
1
2009
247
0.030
Why?
Child
2
1995
3897
0.030
Why?
Statistics as Topic
1
2007
177
0.030
Why?
Clinical Trials, Phase III as Topic
1
2006
9
0.030
Why?
Medical Futility
1
2006
9
0.030
Why?
Oregon
1
1986
21
0.030
Why?
Prodrugs
1
2006
22
0.030
Why?
Bayes Theorem
1
2006
38
0.030
Why?
International Cooperation
1
2006
64
0.030
Why?
Tomography, X-Ray Computed
1
1990
729
0.030
Why?
Nutritional Status
1
2006
44
0.030
Why?
Photic Stimulation
1
2007
223
0.030
Why?
DNA Mutational Analysis
1
2006
185
0.030
Why?
Meta-Analysis as Topic
1
2005
36
0.030
Why?
Tetrabenazine
1
2005
5
0.030
Why?
Fluorine Radioisotopes
1
2005
8
0.030
Why?
Dihydroxyphenylalanine
1
2005
22
0.030
Why?
Ganglia, Spinal
1
2005
42
0.030
Why?
Videotape Recording
1
2005
48
0.030
Why?
Carbon Radioisotopes
1
2005
75
0.030
Why?
Karnofsky Performance Status
1
2004
15
0.030
Why?
Receptors, Dopamine
1
2005
24
0.030
Why?
Body Mass Index
1
2006
207
0.030
Why?
Life Tables
1
2004
35
0.030
Why?
Fluorodeoxyglucose F18
1
2005
17
0.030
Why?
Intelligence Tests
1
2004
41
0.030
Why?
Depression
2
1995
419
0.030
Why?
Dopamine Plasma Membrane Transport Proteins
1
2004
32
0.030
Why?
Biotransformation
1
2005
113
0.030
Why?
New York
1
2009
1191
0.030
Why?
Iodine Radioisotopes
1
2005
98
0.030
Why?
Affect
1
2004
73
0.030
Why?
Drug Combinations
1
2004
142
0.030
Why?
Drug Synergism
1
2004
149
0.030
Why?
Models, Immunological
1
2004
62
0.030
Why?
Membrane Transport Proteins
1
2004
63
0.030
Why?
Cocaine
1
2005
78
0.030
Why?
Blood-Brain Barrier
1
2005
103
0.030
Why?
Stem Cell Transplantation
1
2005
108
0.030
Why?
Ocular Motility Disorders
1
2003
9
0.030
Why?
Age Factors
1
2006
1060
0.030
Why?
Cytoprotection
1
2002
35
0.030
Why?
Motor Skills
1
2002
46
0.030
Why?
Membrane Glycoproteins
1
2004
350
0.020
Why?
Nerve Tissue Proteins
1
2004
310
0.020
Why?
Patient Compliance
1
2002
170
0.020
Why?
Disability Evaluation
1
2000
125
0.020
Why?
Multivariate Analysis
1
2001
487
0.020
Why?
Body Weight
1
2000
328
0.020
Why?
Socioeconomic Factors
1
1999
364
0.020
Why?
Muscle Weakness
1
1997
39
0.020
Why?
Netherlands
1
1997
28
0.020
Why?
Cross-Cultural Comparison
1
1997
30
0.020
Why?
Factor Analysis, Statistical
1
1997
56
0.020
Why?
Ethics, Professional
1
1996
7
0.020
Why?
Drug Tolerance
1
1996
34
0.020
Why?
Bias (Epidemiology)
1
1996
41
0.020
Why?
Safety Management
1
1996
26
0.020
Why?
Nerve Regeneration
1
1996
40
0.020
Why?
Graft Survival
1
1996
145
0.020
Why?
Neuronal Plasticity
1
1996
92
0.020
Why?
Gadolinium DTPA
1
1993
51
0.010
Why?
AIDS-Related Opportunistic Infections
1
1993
54
0.010
Why?
Contrast Media
1
1993
269
0.010
Why?

Visualizations


Kieburtz's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department